Utama › Kanser Kolon › Florida › Tampa
Kajian klinikal Kanser Kolon di Tampa, FL
13 kajian untuk Kanser Kolon sedang mencari peserta di lokasi dalam dan sekitar Tampa (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Mengambil pesertaFasa 1
- ALX Center 7, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Mengambil pesertaFasa 3
- Tampa General Hospital-Cancer Institute, Tampa
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Mengambil pesertaFasa 2/3
- Tampa General Hospital, Tampa
- Moffitt Cancer Center-International Plaza, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
- dan 2 lagi
Shield Post-Approval Study Protocol
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- NMC Research, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Mengambil pesertaFasa 1
- Moffitt Cancer Center, Tampa
Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
Mengambil peserta
- Tampa General Hospital, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
Kajian Kanser Kolon di bandar lain
- Boston, MA22 kajian
- New York City, NY22 kajian
- Houston, TX20 kajian
- Los Angeles, CA16 kajian
- Nashville, TN16 kajian
- St. Louis, MO15 kajian
- Arlington, VA15 kajian
- Chicago, IL14 kajian
- San Antonio, TX14 kajian
- Baldwin Park, CA14 kajian
- Baltimore, MD13 kajian
- Washington, DC12 kajian
Kajian lain di Tampa
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser Payudara43 kajian
- Kanser (semua jenis)39 kajian
- Kanser Kolorektal34 kajian
- Leukemia Mieloid Akut29 kajian
- Kanser Metastatik29 kajian
- Kanser Paru-paru29 kajian
- Kanser Pankreas26 kajian
- Kanser Ovari21 kajian
- Melanoma19 kajian
- Sindrom Mielodisplastik19 kajian
- Kanser Prostat18 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.